-
Symbol
-
SABS on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
5.17M shares
-
Security Ownership
-
9.99%
BVF PARTNERS L P/IL ownership in SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS)
2025-11-14 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.17M shares of SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS).
This represents 9.99% percent ownership of the company.